Semaglutide 2.4mg (Wegovy) is contraindicated in pregnancy, while other GLP-1 receptor agonists are generally not recommended
The most significant change to dining habits among GLP-1 users is that they report eating smaller portion sizes since beginning their medication, which is likely a direct result of the medication acting to suppress appetite
If not able to eat normally, replace meals with high-carbohydrate snacks or drinks
Ensuring adequate intake helps reduce fatigue, protect muscle, and maintain resting energy expenditure during active weight loss
Exploring related treatment pathways For patients who find GLP-1 medications financially inaccessible after the coverage changes, understanding the broader peptide landscape can reveal alternative or complementary approaches to health optimization
Three minutes after being placed in the box, they were presented with three tones (4kHz, 80 dB, 30 seconds), 60 seconds apart